Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia.
Clin Infect Pract
; 7: 100037, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-628667
ABSTRACT
BACKGROUND:
In December 2019, a novel communicable disease, novel coronavirus infected pneumonia (NCIP) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) broke out. We aimed to analyze the characteristics and severity of patients with myocardial damage in NCIP.METHODS:
We enrolled 215 adult patients with NCIP from January 2020 to February 2020. Outcomes were followed up until March 1st, 2020.RESULTS:
28.37% of the total patients showed increased level of TnI (> 0.040â¯ng/ml). Patients were older and had more cardiovascular complications in increased TnI group. Higher CRP, NT-proBNP, lower immune CD3, CD4 and CD8 cell account and more involved lobes detected by CT scan in the lung were observed in increased TnI group. Patients with elevated TnI had higher CURB-65 scores and were more likely given glucocorticoid therapy and mechanical ventilation than patients in normal TnI group.CONCLUSIONS:
Markers of cardiomyocyte injury were elevated not least in elderly males with pre-existing cardiovascular disease. Patients with elevated TnI presented more severe situation, leading to multiple organ dysfunctions, which appeared as a pivotal feature of patients with NCIP that requires attention by clinicians in order to provide necessary treatment as soon as possible and improve patients' outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Clin Infect Pract
Year:
2020
Document Type:
Article
Affiliation country:
J.clinpr.2020.100037
Similar
MEDLINE
...
LILACS
LIS